Transcriptional regulation of protease-inhibitor Maspin in breast epithelial- and breast cancer-cellines;Transkriptionelle regulierung des protease-inhibitors maspin in brustepithel- und Brustkrebs-Zellen

Tumor Diagnostik und Therapie

Volumn 18, Issue 4, 1997, Pages 89-96

  Maass, N ^a,b   Zhang, M ^b   Sager, Ruth ^b   Jonat, W ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

AP 1; Breast cancer; Maspin; PEA 3; Protease inhibitor; Transcription factors

Indexed keywords

SERINE PROTEINASE INHIBITOR;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PROMOTER REGION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 0030767120     PISSN: 0722219X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Al-Moslih M I, Dubes G R: DEAE-Dextran Transfection. J. Gen. Virol. 18 (1973) 189
2. Band V, Sager R: Distinctive trait of normal and tumor derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 1249-1253
3. Chen W T: Membrane proteases: roles in tissue remodeling and tumor invasion. Current Opin. Cell Biol. 4 (1992) 802-809
4. Dalton S, Treismann R: Characterization of Sap-1, a protein recruited by serum response factor to the c-fos serum response element. Cell 68 (1992) 597-612
5. Dignam J, Lebovitz R, Roeder R: Accurate transcription initiation by RNA polymerase II in a soluble extract isolation from mammalian nuclei. Nuc. Acid. Res 11 (1983) 1475-1489
6. Duffy M J, Reilly D C, Andreasen P A: Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer. Canc. Res. 50 (1990) 6827-6829
7. Gettins P, Patston P A, Schapira M: Structure and mechanism of action of serpins. Hematology-Oncology Clinics of North America 6 (1992) 1393-1408
8. Gorman C M, Moffat L F, Howard B H: Recombinant genomes which expressed chloramphenicol acetyl transferase in mamalian cells. Mol. CellBiol. 2 (1982) 1044-1057
9. Gutman A, Wasylyk B: The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA-3 and AP-1 binding sites. EMBO 9 (1990) 2241-2246
10. Lee S, Tornasetto C, Sager R: Down regulation of a new member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxcytidine treatment. Proc. Natl. Acad. Sci USA 89 (1992a) 2504
11. Liotta L A, Steeg P S, Stetler-Stevenson W G: Cancer metastasis and angiogenesis: imbalance of positive and negative regulation. Cell 64 (1991) 327-336
12. Love J, Li X, Case D, Giese K, Wright P: Structural basis for DNA bending by the architetural transcription factor LEF-1. Nature 376 (1995) 791-795
13. Mavrothalassitis G J, Papas T: Positive and negative factors regulate the transcription of the ETS2 gene via an oncogene-responsive-like unit within the ETS2 promotor region. Cell Growth & Diff. 2 (1991) 215-224
14. Nerlov C, Rorth P, Blasi F, Johnsen M: Essential AP-1 and PEA-3 binding elements in the human urokinase enhancer display cell typespecific activity. Oncogene 6 (1991) 1583-1592
15. Nerlov C, Cesare D, Blasi F, Verde P: A regulatory element that mediates cooperation between a PEA-3-AP-1 element and an AP-1 site is required for phorbolester induction of urokinase enhancer in HepG2 cells. EMBO 11 (1992) 4573-4582
16. Petersen J M, Skalicky J J, Donaldson L W, Gravest B J: Modulation of transcription factor Ets-1 DNA binding. Science 269 (1995) 1866-1869
17. Potempa J, Korzus E, Travis J: The Serpin Superfamily of Proteinase Inhibitors: Structure, Function and Regulation. J. Biol. Chem. 269, No 23 (1994) 15957-15960
18. Schneider S S, Schick C, Fish K E, Silverman G A: A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc. Natl. Acad. Sci. USA 92 (1995) 3147-3151
19. Scott G, Daniel J C, Benz C C: Binding of an ETS-related protein within the DNasel hypersensitve site of the HER2/neu promoter in human breast cancer cells. J. Biol. Chem. 269 (1994) 19848-19858
20. Sheng S, Pemberton P A, Sager R: Production, purification and charakterization of recombinant maspin proteins. J. Biol. Chem. 269 (1994) 30988-30993
21. Swisshelm K, Ryan K, Lee X, Tsou H C, Sager R: Down-regulation of retinoic acid receptor b in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth & Differ. 5 (1994) 133-141
22. Treier M, Bohmann D, Mlodzik M: Jun cooperates with the ETS domain protein pointed to induce photoreceptor R7 fate in the drosophila eye. Cell 83 (1995) 753-760
23. Wasylyk B, Wasylyk C, Flores P, Begue, Leprince D, Stehelin D: The c-ets protooncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation. Nature 346 (1990) 191-193
24. Wasylyk C, Flores P, Gutman A, Wasylyk B: EMBO 8 (1989) 3371-3378
25. Watson D K, Ascione R, Papas T: Molecular analysis of the ETS Gene and their products. Crit. Rev. Oncog. 1 (1990) 409-436
26. Werner M H, Clore G M, Fisher C L, Gronenborn A M: The solution structure of the human ETS1-DNA complex reveals a novel mode of binding a true side chain intercalation. Cell 83 (1995) 761-771
27. Wickelgren I: Protein sculptures that help turn on genes. Science 270 (1995) 1587
28. Zhang M, Maass N, Sheng S, Sager R: mMaspin, the mouse homolog of a human tumor suppressor gene, inhibits mammary tumor invasion and motility. Molec. Med. angenommen Dez. 1996
29. Zou Z, Anisowicz A, Hendrix M J C, Thor A, Neveu M, Sheng S K et al.: Identification of a novel serpin with tumor suppressing activity in human mammary epithelial cells. Science 263 (1994) 526-529